FDA adcomm to review Capricor’s Duchenne cell therapynews2025-05-05T20:07:53+00:00May 5th, 2025|Endpoints News|
J&J eye disease gene therapy bota-vec fails Phase 3news2025-05-05T13:29:50+00:00May 5th, 2025|Endpoints News|
Early in vivo CAR-T human data emerge from biotech trials in Chinanews2025-05-05T10:00:52+00:00May 5th, 2025|Endpoints News|
Vertex drops AAV gene therapy research, tRNA therapy partnershipnews2025-05-02T19:29:13+00:00May 2nd, 2025|Endpoints News|
Feng Zhang’s protein nanoparticle startup Aera Therapeutics turns to lipid nanoparticles to jumpstart its pipelinenews2025-05-02T15:32:11+00:00May 2nd, 2025|Endpoints News|
Bristol Myers to close cell therapy site in Illinoisnews2025-05-01T18:42:48+00:00May 1st, 2025|Endpoints News|
FDA approves Abeona’s skin disease cell therapynews2025-04-29T15:06:37+00:00April 29th, 2025|Endpoints News|
RFK Jr. touts program testing ways to pay for sickle cell carenews2025-04-25T17:12:04+00:00April 25th, 2025|Endpoints News|
Caribou lays off 32% of staff, cuts lupus programnews2025-04-24T20:15:36+00:00April 24th, 2025|Endpoints News|
Ayrmid misses deadline for detailed offer to top private equity bid for bluebirdnews2025-04-16T13:48:58+00:00April 16th, 2025|Endpoints News|
